Respiratory Technology

Our preference is to find opportunities that are on-market, market-ready, or require limited development.


Opportunities may consist of new product forms, packaging innovations, delivery technologies, or new products.

Description of the need:

We are interested in opportunities (i.e. products and technologies) that complement our Respiratory portfolio (DayQuil, NyQuil, Sinex and ZzzQuil) and are capable of delivering any or all of the following benefits:

  • Providing new, or augmenting already established health claims

  • Increasing consumer satisfaction

  • Enhancing consumer compliance

  • Enabling greater convenience

Areas of interest are:

  • Technology Delivery methods (e.g. targeted, faster, delayed, etc.)

  • Products with claimable health benefits

  • New and novel product forms

  • New packaging (e.g., portable, convenient, etc.)

Opportunities must have (where applicable):

  • Human clinical data

  • Human safety data, NDI designation, or GRAS status

  • Stability data

  • Freedom to market

We are not interested in:

  • Opportunities that require extensive technical or clinical development

  • Opportunities with unknown regulatory path

  • Opportunities that require significant investment to complete their development